eli lilly and company

Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial

Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial

Scans that illustrate the differences in three brains: a person who’s brain is healthy, left, one with mild cognitive impairment, center, and one with Alzheimer’s disease.
Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial

Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial

Scans that illustrate the differences in three brains: a person who’s brain is healthy, left, one with mild cognitive impairment, center, and one with Alzheimer’s disease.
Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial

Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial

Scans that illustrate the differences in three brains: a person who’s brain is healthy, left, one with mild cognitive impairment, center, and one with Alzheimer’s disease.
Drug Makers Accused of Fixing Prices on Insulin

Drug Makers Accused of Fixing Prices on Insulin

Dr. Julian Nussbaum, an ophthalmologist, discussing eye health with a diabetes patient.
Drug Makers Accused of Fixing Prices on Insulin

Drug Makers Accused of Fixing Prices on Insulin

Dr. Julian Nussbaum, an ophthalmologist, discussing eye health with a diabetes patient.
Drug Makers Accused of Fixing Prices on Insulin

Drug Makers Accused of Fixing Prices on Insulin

Dr. Julian Nussbaum, an ophthalmologist, discussing eye health with a diabetes patient.
He Raised Drug Prices at Eli Lilly. Can He Lower Them for the U.S.?

He Raised Drug Prices at Eli Lilly. Can He Lower Them for the U.S.?

Alex M. Azar II in 2006, when he was deputy health and human services secretary under President George W. Bush. He will begin confirmation hearings this week to head the department under President

Trump’s HHS Nominee Harps on Rising Drug Prices in Senate Hearing

Alex Azar underwent his first Senate confirmation hearing on Wednesday.
Health Nominee Grilled on Commitment to Lower Drug Prices

Health Nominee Grilled on Commitment to Lower Drug Prices

Alex M. Azar II echoed Republican criticism of the Affordable Care Act during a confirmation hearing to be secretary of health and human services on Wednesday.
Many People Taking Antidepressants Discover They Cannot Quit

Many People Taking Antidepressants Discover They Cannot Quit

Victoria Toline needed nine months to taper off Zoloft. “I had to drop out of school,” she said. “My life’s been on hold.”
Many People Taking Antidepressants Discover They Cannot Quit

Many People Taking Antidepressants Discover They Cannot Quit

Victoria Toline needed nine months to taper off Zoloft. “I had to drop out of school,” she said. “My life’s been on hold.”
Many People Taking Antidepressants Discover They Cannot Quit

Many People Taking Antidepressants Discover They Cannot Quit

Victoria Toline needed nine months to taper off Zoloft. “I had to drop out of school,” she said. “My life’s been on hold.”
Many People Taking Antidepressants Discover They Cannot Quit

Many People Taking Antidepressants Discover They Cannot Quit

Victoria Toline needed nine months to taper off Zoloft. “I had to drop out of school,” she said. “My life’s been on hold.”
Many People Taking Antidepressants Discover They Cannot Quit

Many People Taking Antidepressants Discover They Cannot Quit

Victoria Toline needed nine months to taper off Zoloft. “I had to drop out of school,” she said. “My life’s been on hold.”
Many People Taking Antidepressants Discover They Cannot Quit

Many People Taking Antidepressants Discover They Cannot Quit

Victoria Toline needed nine months to taper off Zoloft. “I had to drop out of school,” she said. “My life’s been on hold.”
For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly

For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly

Vicki Staehr, who lives in Orlando, Fla., has enrolled in a clinical trial for an experimental Alzheimer’s treatment intended to slow memory loss.
For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly

For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly

Vicki Staehr, who lives in Orlando, Fla., has enrolled in a clinical trial for an experimental Alzheimer’s treatment intended to slow memory loss.
For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly

For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly

Vicki Staehr, who lives in Orlando, Fla., has enrolled in a clinical trial for an experimental Alzheimer’s treatment intended to slow memory loss.
For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly

For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly

Vicki Staehr, who lives in Orlando, Fla., has enrolled in a clinical trial for an experimental Alzheimer’s treatment intended to slow memory loss.

Big Pharma’s Hunt for New Drugs Is Pushing Up Cost of Deals

Just two months into the year, the value of acquisitions of American biotech companies has already exceeded last year’s total.
undefined